Now On-Demand | Click below to view
Abingdon Health joined other lateral flow companies from the UK and USA to discuss the future of the lateral flow industry. The market is projected to reach USD 10.2 billion (marketsandmarkets.com) by 2025 but hear why this is the case.
Lateral flow rapid tests have been crucial in the global response to the COVID-19 pandemic and will be a major part of the world’s return to normality. In this 30-minute webinar, Leigh Thomas, Senior VP, Director of Global Sales at Abingdon Health, joined other global lateral flow industry thought-leaders to discuss the positive future for these rapid tests.
Who should attend?
- Organisations with a lateral flow test concept who need future market-validation to proceed with an assay development project
- Companies looking for insight into the next market opportunity
- Organisations looking to enter their market with a lateral flow test
If you’re working on a lateral flow assay (LFA) project and need assistance with development, scale-up or manufacture, please call +44 (0) 1904 406082 or contact us online.
Watch On-Demand Here
Catch every insightful minute of the What’s Next for Lateral Flow? webinar by clicking on the video below.
This webinar took place on Wednesday 26th May 2021.